Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs SK Telecom Co. Ltd. Common Stock (SKM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs SK Telecom Co. Ltd. Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while SK Telecom Co. Ltd. Common Stock trades at $32.32 (market cap $12.77B). The key difference: SK Telecom Co. Ltd. Common Stock is the larger of the two by market cap, and SK Telecom Co. Ltd. Common Stock pays a 2.82% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and SK Telecom Co. Ltd. Common Stock for 6 Days on average.
| KYMR | SKM | |
|---|---|---|
Market Cap | $8.87B | $12.77B |
Volume | 779,107 | 1,991,125 |
Sector | Health | Media |
52-Week High | $127.31 | $46.00 |
52-Week Low | $55.80 | $19.68 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $8.26B | $18.85B |
Dividend Yield | — | 2.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SKM trades at $34.42, up 2.9% today, showing strong earnings momentum with three consecutive quarterly beats. The stock faces technical headwinds with a bearish moving average signal despite oversold RSI conditions. Fundamentally, the company demonstrates robust gross margins of 87.51% but modest net income margins of 4.38%, with recent AI data center spin-offs creating potential value catalysts.
Outlook remains balanced with analyst consensus divided (42.85% Buy, 42.86% Hold) amid AI infrastructure expansion opportunities. Key risks include negative cash flow trends and competitive pressures in wireless communications. The current valuation at 24.39 P/E appears reasonable given growth initiatives, but execution on data center strategy will determine future performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About SK Telecom Co. Ltd. Common Stock
SK Telecom is a South Korean telecommunications company providing mobile, broadband, and digital services. It also develops services in areas such as AI, cloud, and data centers.
Read more on SKM →
